An innate defence role for BPIFA1/SPLUNC1 against influenza-A virus infection

Khondoker Akram (Sheffield, United Kingdom), Khondoker Akram, Nathifa Moyo, Mark Tompkins, Ralph Tripp, Lynne Bingle, James Stewart, Colin Bingle

Source: International Congress 2015 – The multiple faces of host defense
Session: The multiple faces of host defense
Session type: Oral Presentation
Number: 1781
Disease area: Airway diseases, Respiratory infections

Congress or journal article abstractSlide presentation

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
Khondoker Akram (Sheffield, United Kingdom), Khondoker Akram, Nathifa Moyo, Mark Tompkins, Ralph Tripp, Lynne Bingle, James Stewart, Colin Bingle. An innate defence role for BPIFA1/SPLUNC1 against influenza-A virus infection. Eur Respir J 2015; 46: Suppl. 59, 1781

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Epigenetic control of antiviral and innate immune response following viral infection in a lung epithelial model
Source: Annual Congress 2013 –New insights into epigenetic mechanisms in the lung
Year: 2013


Role of the immunoregulatory microRNA miR-146a in the innate immune response to rhinovirus infection
Source: Annual Congress 2013 –Viral infections: what is new?
Year: 2013


Validation of an in vitro tracheal model for the study of innate host defence mechanism in respiratory tract infections
Source: International Congress 2014 – Cells, biofilms and biomarkers in respiratory infections
Year: 2014


Modulation of the innate and adaptive immune system during coronavirus infection.
Source: Virtual Congress 2021 – Emerging respiratory diseases: state-of-the-art studies of SARS-CoV-2 infection
Year: 2021



Innate immunity in the lung: how epithelial cells fight against respiratory pathogens
Source: Eur Respir J 2004; 23: 327-333
Year: 2004



LSC Abstract – The expression and function of BPIFA1 in the pulmonary innate immune response to influenza A virus infection
Source: International Congress 2015 – Viral infections: basic research and clinical perspective
Year: 2015

Infectious Human Rhinovirus persists in in vitro human nasal epithelial cells with waning induction of corresponding innate immune signatures activation
Source: International Congress 2019 – Mechanisms underlying respiratory infection
Year: 2019

Influenza virus infection of human ciliated respiratory epithelial cells in culture
Source: Annual Congress 2013 –Research questions on how viruses affect the respiratory system
Year: 2013


Investigation of the innate antiviral response to respiratory syncytial virus
Source: International Congress 2015 – Paediatric pulmonary infections: mechanisms and treatment
Year: 2015


The innate defence peptide BPIFA1/SPLUNC1 restricts respiratory viral infections
Source: International Congress 2019 – Infections, the microbiome and host defence peptides in the development and progression of asthma
Year: 2019


Type I interferons and IL-15 regulate antiviral cellular responses to rhinovirus infection
Source: Annual Congress 2013 –Viral infections: what is new?
Year: 2013

Inducible epithelial resistance modulates innate antiviral signaling against coronavirus and influenza
Source: Virtual Congress 2021 – Back to infection basics
Year: 2021

Tropism and innate host responses of influenza A/H5N6 virus: an analysis of ex vivo and in vitro cultures of the human respiratory tract
Source: Eur Respir J , 49 (3) 1601710; DOI: 10.1183/13993003.01710-2016
Year: 2017



Efficacy of IFN-λ1 to protect human airway epithelial cells against rhinovirus 1B infection
Source: Annual Congress 2013 –Viral infections
Year: 2013


IP-10 is selectively produced in the airways upon respiratory virus infection
Source: Annual Congress 2013 –Macrophages, mononuclear cells and viral infection
Year: 2013


MAIT cells contribute to a protective antiviral innate response to influenza infection
Source: International Congress 2018 – New therapies for respiratory infections: experimental and translational studies
Year: 2018